Posts Tagged: agency
Berkeley City College, which received a portion of $51 million in state stem cell research grants. (Photo: berkeleyside.org)
The California stem cell agency has awarded $51 million to help train students in the art of research at the Golden State’s community colleges and universities. All 15 applicants for awards that ran as high as $3.6 million each were approved, including Berkeley City College, which was initially rejected by anonymous reviewers who met privately prior to the ratification of their decisions by the agency’s directors.
Evangelina, a former 'bubble baby,' plays inside a giant plastic bubble. (Photo: Stem Cellar Report, CIRM)
Little Evangelina Padilla-Vaccaro is more than a poster girl for the $12 billion California stem cell agency. She embodies a big bet by the agency that its efforts will conquer at least a few of the terrible diseases that are currently incurable. In the case of Evie, as the eight-year-old is known, she was born with what has come to be described as the bubble baby syndrome, a rare genetic mutation that crippled her immune system to the point that she would have died if left untreated.
A stem cell researcher at UC Davis. (Photo: AJ Cheline, UC Davis, via The Stem Cellar)
Backed by $17 million in cash from California’s stem cell agency, researchers at UC Davis this month are launching “the world’s first clinical trial using stem cells to treat spina bifida before the child is born.”
Stem cell researcher and professor Larry Goldstein. (Photo: Screen capture, UCTV).
Larry Goldstein, a well-known stem cell researcher at the University of California, San Diego who has received nearly $22 million in awards from the California stem cell agency, today was named to its governing board. It was the first time in the history of the 16-year-old agency that a scientist who has received agency awards has been appointed to the board.
Personnel at UCSF's facility in Fresno, which may benefit if Proposition 14 is approved. (Photo: UCSF)
Proposition 14, the fall ballot measure to save California’s stem cell agency from financial extinction, contains much, much more than the $5.5 billion that it is seeking from the state’s voters. Added to the agency’s charter would be research involving mental health, “therapy delivery,” personalized medicine and “aging as a pathology.“ That is not to mention a greater emphasis on supporting “vital research opportunities” that are not stem cell-related.
A laboratory stem cell researcher uses a laptop in conjunction with a microscope. (Photo: moreimages, via Shutterstock)
A small firm in Menlo Park, Ca., is probably the only company in the nation that is named after the number of a particular human protein. It is a small number too, only 47. But it has large implications for California’s financially strapped state stem cell agency.
A pipette and vessels usd in stem cell research. (Photo: CI Photos, via Shutterstock)
The price tag for refinancing California’s unique and ambitious stem cell research program could run to close to $7.8 billion, give or take a few hundred million dollars or more. So says the state’s legislative analyst in a financial analysis of a proposed ballot initiative that is likely to be on next November’s ballot.
Testing cosmetics on a laboratory rabbit. (Photo: Artfully Photographer, via Shutterstock)
Animal-rights activists are heralding 2020 as a groundbreaking year because of a new, unprecedented state law that cracks down on cosmetics testing on animals. It takes effect Jan. 1, and will outlaw the importation for profit or sale most of the cosmetics tested on animals in California.
Stem cells for treating cancer in microtubes. (Image: Science Photo, via Shutterstock)
Backers of the financially stressed California stem cell agency yesterday filed their proposed ballot measure to refinance the agency with $5.5 billion if voters approve it in November 2020. The complex, 30-page initiative would also restructure a number of aspects of the agency and provide for financial assistance for patients and their families who might be involved in clinical trials.
View toward downtown Los Angeles and surrounding communities on a hot, smoggy day. (Image: IM_Photo, via Shutterstock))
OPINION: The Trump administration’s Environmental Protection Agency offered another boon to the fossil fuel industry when it announced its intent to ignore the scientifically-proven impacts of air pollution on human health. By minimizing and outright denying the health risks of air pollution, the EPA is recklessly devaluing the lives of children and families who are assaulted daily by pollution and climate impacts that threaten their health, safety, and life expectancy.